Implantable Hearing Device Enters Key Trial Phase
Adults with significant hearing loss may one day use a device with no external sound processor, though results are still pending.
Updated on Nov. 3, 2026 in Stroke

Live Poll
Would you want a hearing implant with no externally worn parts?
Cochlear has completed enrollment of 92 patients across two pivotal studies of its fully implantable hearing technology, with the investigational system's microphone, sound processing chip, and battery placed beneath the skin. Adults with hearing loss in the U.S., Australia, and France were among those enrolled, and the company plans a six-month primary analysis of safety and effectiveness.
Why it matters
For people with significant hearing loss, a device that works without an externally worn sound processor could change daily routines around charging and wearing hardware. Fully implantable hearing technology remains investigational, so its safety and benefit are not yet established outside the trial setting.
These are company-run pivotal studies that have completed enrollment, with results not yet reported. Across all pivotal and feasibility studies since 2005, 117 patients have been enrolled, and more than 100 patients have received the company's fully implantable hearing technology.
The players
Cochlear
Sydney-based company that makes cochlear implants and the Nucleus Nexa smart cochlear implant system, and is developing fully implantable hearing technology.
The details
The investigational TICI system places a dual microphone, a sound processing chip, and a rechargeable battery inside the implantable device beneath the skin. Because the microphone sits under the skin rather than on the outside of the head, the system is designed to provide hearing without an externally worn sound processor during everyday use. The company has been developing this approach for more than 20 years.
Timeline
2005: Cochlear's feasibility studies of implantable hearing technology began.
Six months after enrollment completion: planned primary analysis of safety and effectiveness.
12 months after enrollment completion: planned end of follow-up for longer-term data.
Health Landscape
Cochlear's commercially available Nucleus Nexa System is a smart cochlear implant with upgradeable firmware, and the company does not expect fully implantable hearing technology to replace traditional cochlear implants. The investigational system is one of several efforts to reduce the external hardware that people with severe hearing loss currently wear.
Fully implantable hearing technology is still investigational and is not available outside clinical trials. If you have significant hearing loss and are weighing options, it is worth discussing with your audiologist or physician which current treatments fit your situation.
The takeaway
Fully implantable hearing technology has completed enrollment in its pivotal trials, but its safety and benefit are not yet reported. Watch for the six-month results, and bring questions about hearing options to your hearing specialist.
What happens next
Cochlear plans a primary analysis of safety and effectiveness at six months after enrollment completion, with follow-up continuing to 12 months.
Further reading
For broader context on related neurological health topics, explore our Stroke coverage.
Source note: This article includes information reported by MDDI Online.
Live Poll
Would you want a hearing implant with no externally worn parts?


